What does a serum insulin level of 37.3 µU/mL indicate?

Interpretation of Serum Insulin Level of 37.3 µU/mL

A serum insulin level of 37.3 µU/mL is elevated and indicates hyperinsulinemia, suggesting insulin resistance, particularly if measured in the fasting state.

Clinical Context and Interpretation

The interpretation of this insulin level depends critically on when it was measured and the concurrent glucose level:

If Measured During Fasting:

• Normal fasting insulin reference range is approximately 2-12 µU/mL 1
• Your value of 37.3 µU/mL is approximately 3 times the upper limit of normal
• This indicates significant hyperinsulinemia and insulin resistance 1
• Fasting insulin >30 µU/mL is associated with poor metabolic control and increased cardiovascular risk 2

If Measured During Hypoglycemia:

This is where the interpretation becomes critically important for diagnosis:

• During true hypoglycemia (glucose <55 mg/dL or 3.0 mmol/L), insulin should be suppressed to <3 µU/mL 3

• An insulin level of 37.3 µU/mL during hypoglycemia is grossly inappropriate and diagnostic of endogenous hyperinsulinism 3, 4

• This finding, combined with:

  • C-peptide ≥0.6 ng/mL (≥0.2 nmol/L)
  • Proinsulin ≥5.0 pmol/L
  • Glucose <55 mg/dL (3.0 mmol/L)

  ...confirms pathologic insulin secretion and warrants investigation for insulinoma or other causes of hyperinsulinemic hypoglycemia 3, 4

Clinical Implications by Scenario

Scenario 1: Elevated Fasting Insulin (Most Likely)

If this is a fasting value with normal or elevated glucose:

• Indicates insulin resistance - the pancreas is overproducing insulin to maintain glucose homeostasis
• Risk stratification: Fasting insulin >9.0 µU/mL identifies prediabetes with 80% accuracy 5
• Your value of 37.3 µU/mL places the patient at very high risk for metabolic syndrome, type 2 diabetes, hypertension, and cardiovascular disease 1, 5
• Associated findings to expect: hypertension (particularly if insulin >30 µU/mL), elevated triglycerides, central obesity 2

Scenario 2: Insulin During Documented Hypoglycemia (Critical)

If measured during symptomatic hypoglycemia:

• This is pathologic and requires urgent evaluation 3
• Next steps per Endocrine Society guidelines 3:
  • Confirm C-peptide and proinsulin are also elevated
  • Screen for oral hypoglycemic agents (sulfonylureas, meglitinides)
  • Check for insulin antibodies
  • Measure β-hydroxybutyrate (should be <2.7 mmol/L if insulin-mediated)
  • Perform glucagon stimulation test (glucose should rise ≥25 mg/dL if insulin-mediated)
• If exogenous drugs and antibodies are negative, proceed to imaging for insulinoma (CT, MRI, endoscopic ultrasound, selective arterial calcium stimulation) 3

Common Pitfalls to Avoid

1. Don't interpret insulin in isolation - always correlate with simultaneous glucose level 3
2. Timing matters - fasting vs. postprandial vs. during hypoglycemia completely changes interpretation
3. Don't miss factitious hypoglycemia - always screen for sulfonylureas and check C-peptide to distinguish endogenous from exogenous insulin 3, 4
4. Assay variability exists - reference ranges may differ slightly between laboratories, but 37.3 µU/mL is elevated by any standard 6

Recommended Action Algorithm

Step 1: Determine the clinical context

• Was this fasting (>8 hours)?
• What was the simultaneous glucose level?
• Were there symptoms of hypoglycemia?

Step 2: If fasting with normal/high glucose:

• Assess for metabolic syndrome components (blood pressure, triglycerides, waist circumference, HDL)
• Implement lifestyle interventions targeting insulin resistance 7
• Consider metformin if prediabetes criteria met 2

Step 3: If during hypoglycemia (glucose <55 mg/dL):

• Immediately measure C-peptide, proinsulin, β-hydroxybutyrate, and screen for sulfonylureas 3
• Check insulin antibodies
• Refer to endocrinology urgently for further evaluation 3, 4